Iranian Society of Gynecology Oncology


1 Department of Obstetrics and Gynecology, Infertility and Reproductive Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran

2 Student, University of Texas Southwestern, School of Medicine, Dallas, TX, USA


Abortion is desperately selected by some females who cannot continue their unintended pregnancies in all societies, some will suffer complications and some will die. Annual number of induced abortion has increased in the developing countries but the maternal death related to unsafe abortion has declined in the world since 2003. Medical abortion has contributes to this decline. In Iran, abortion rate of one per four female is estimated. The current study evaluated the technique of induced abortion among mothers with parity score of 0 - 1 (0.49), who attempted abortion; approximately 65 females performed induced abortion medically by misoprostol in 50.7%, surgically by curettage in 28% and manual vacuum aspiration (MVA) or vacuum curettage in 18% of the cases at the gestational age of six weeks. Since previously mentioned technique of abortion was surgical; the unsafe and clandestine abortions with 1.35% maternal death in the 1990s later changed to medical abortion by dinoprostone (prostaglandin E2) in the 2000s and now medical abortion is replaced by misoprostol (prostaglandin E1) in the 2010s. Complete abortion occurred in approximately 60% of the misoprostol cases. The parity score and gestational age in abortion cases have declined. Failure of withdrawal method of contraception (57%) and unmet need to modern effective contraception are contributing factors in these abortions. The trends in abortion are replaced by medical abortion with less morbidity at earlier stages of pregnancy. Traditional contraception and lack of effective contraceptive facilities and accessibilities are likely to increase unintended pregnancies and consequently abortions as well.


  1. World Health Organization . Unsafe abortion: global and regional estimates of the incidence of unsafe abortion and associated mortality in 2008. 6th ed. Geneva: World Health Organization; 2011.
  2. Guttmacher Institute . Facts on induced abortion worldwide. World wide incidence and trends New York: Guttmacher Institute; 2012. Available from:
  3. Erfani A, McQuillan K. Rates of induced abortion in Iran: the roles of contraceptive use and religiosity. Stud Fam Plann. 2008;39(2):111-22. [DOI:10.1111/j.1728-4465.2008.00158.x]
  4. Fallahian M, Nowroozy A. Maternal mortality and morbidity due to unsafe abortion in Iran [in Persian]. Int J Gynecol Obstet. 1994;18:55-9.
  5. Fallahian M, Mohammadzadeh F. Trends in abortion in Iran: 1994-2002. Arch Iranian Medicine. 2005;8:217-8.
  6. WHO . World Health Organization's List of Essential Medicines, a list of the most important medication needed in a basic health system 2013. Available from:
  7. Coelho HL, Teixeira AC, Cruz Mde F, Gonzaga SL, Arrais PS, Luchini L, et al. Misoprostol: the experience of women in Fortaleza, Brazil. Contraception. 1994;49(2):101-10. [DOI:10.1016/0010-7824(94)90084-1]
  8. Sydsjo A, Josefsson A, Bladh M, Sydsjo G. Trends in induced abortion among Nordic women aged 40-44 years. Reprod Health. 2011;8:23. [DOI:10.1186/1742-4755-8-23]
  9. Sedgh G, Singh S, Shah IH, Ahman E, Henshaw SK, Bankole A. Induced abortion: incidence and trends worldwide from 1995 to 2008. Lancet. 2012;379(9816):625-32. [DOI:10.1016/S0140-6736(11)61786-8]
  10. National Institute for Health Research (NIHR) . Health Observatory: First Report of the Islamic republic of Iran's Multiple- Indicator Demographic and Health Survey 2010 [In Persian] Tehran, Iran: Ministry of Health and Medical Education; 2012. Available from:
  11. Erfani A, Yuksel-Kaptanoglu I. The use of withdrawal among birth limiters in Iran and Turkey. Stud Fam Plann. 2012;43(1):21-32. [DOI:10.1111/j.1728-4465.2012.00299.x]
  12. Amy JJ. The shortest lecture on fertility control. Eur J Contracept Reprod Health Care. 2009;14(5):321-3. [DOI:10.3109/02652040903244831]